The Strategies of Development of New Non-Toxic Inhibitors of Amyloid Formation

The Strategies of Development of New Non-Toxic Inhibitors of Amyloid Formation

In recent years, due to the aging of the population and the development of diagnostic medicine, the number of identified diseases associated with the accumulation of amyloid proteins has increased. Some of these proteins are known to cause a number of degenerative diseases in humans, such as amyloid...

Full description

Bibliographic Details
Main Authors:	Oxana V. Galzitskaya, Sergei Y. Grishin, Anna V. Glyakina, Nikita V. Dovidchenko, Anastasiia V. Konstantinova, Sergey V. Kravchenko, Alexey K. Surin
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	International Journal of Molecular Sciences
Subjects:	amyloid α-synuclein insulin amyloid-beta Alzheimer’s disease Parkinson’s disease
Online Access:	https://www.mdpi.com/1422-0067/24/4/3781

Similar Items

Secondary Nucleation and the Conservation of Structural Characteristics of Amyloid Fibril Strains
by: Saeid Hadi Alijanvand, et al.
Published: (2021-04-01)

Amyloids of α-Synuclein Promote Chemical Transformations of Neuronal Cell Metabolites
by: Istvan Horvath, et al.
Published: (2023-08-01)

Functional genomic analyses uncover APOE-mediated regulation of brain and cerebrospinal fluid beta-amyloid levels in Parkinson disease
by: Laura Ibanez, et al.
Published: (2020-11-01)

Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro
by: Janett Köppen, et al.
Published: (2020-01-01)

Autophagy Modulation as a Treatment of Amyloid Diseases
by: Zoe Mputhia, et al.
Published: (2019-09-01)

How Lazy Reading and Semantic Sloppiness May Harm Progress in Synucleinopathy Research
by: Erwan Bezard
Published: (2022-01-01)

Squalamine and Its Derivatives Modulate the Aggregation of Amyloid-β and α-Synuclein and Suppress the Toxicity of Their Oligomers
by: Ryan Limbocker, et al.
Published: (2021-06-01)

Parkinson’s Disease Dementia: Synergistic Effects of Alpha-Synuclein, Tau, Beta-Amyloid, and Iron
by: Jiajun Han, et al.
Published: (2021-10-01)

α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson’s Disease Patients and Correlate with Disease Severity
by: Simona Daniele, et al.
Published: (2018-02-01)

Development of Small Molecules Targeting α-Synuclein Aggregation: A Promising Strategy to Treat Parkinson’s Disease
by: Samuel Peña-Díaz, et al.
Published: (2023-03-01)

Amyloid Fragmentation and Disaggregation in Yeast and Animals
by: Vitaly V. Kushnirov, et al.
Published: (2021-12-01)

Astemizole, a Second-Generation Histamine H1-Receptor Antagonist, Did Not Attenuate the Aggregation Process of α-Synuclein In Vitro
by: Jung Il Choi, et al.
Published: (2024-03-01)

Seeking a Mechanism for the Toxicity of Oligomeric α-Synuclein
by: Hazel L. Roberts, et al.
Published: (2015-03-01)

Monitoring α-synuclein aggregation
by: Juan Estaun-Panzano, et al.
Published: (2023-01-01)

Graphene-Based Nanoparticles as Potential Treatment Options for Parkinson’s Disease: A Molecular Dynamics Study
by: Alimohammadi E, et al.
Published: (2020-09-01)

Effects of the Toxic Metals Arsenite and Cadmium on α-Synuclein Aggregation In Vitro and in Cells
by: Emma Lorentzon, et al.
Published: (2021-10-01)

Effect of superparamagnetic nanoparticles coated with various electric charges on α-synuclein and β-amyloid proteins fibrillation process
by: Javdani N, et al.
Published: (2019-01-01)

Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's Disease
by: Mahsa Dolatshahi, et al.
Published: (2018-07-01)

ZPD-2, a Small Compound That Inhibits α-Synuclein Amyloid Aggregation and Its Seeded Polymerization
by: Samuel Peña-Díaz, et al.
Published: (2019-12-01)

The Mechanisms of the Roles of α-Synuclein, Amyloid-β, and Tau Protein in the Lewy Body Diseases: Pathogenesis, Early Detection, and Therapeutics
by: Moeko Noguchi-Shinohara, et al.
Published: (2023-06-01)

Catechins as Tools to Understand the Molecular Basis of Neurodegeneration
by: Karla Martinez Pomier, et al.
Published: (2020-08-01)

Structure Activity Relationship of Phenolic Acid inhibitors of α-Synuclein Fibril Formation and Toxicity
by: Mustafa eArdah, et al.
Published: (2014-08-01)

Cerebrospinal Fluid <i>α</i>-Synuclein Species in Cognitive and Movements Disorders
by: Vasilios C. Constantinides, et al.
Published: (2021-01-01)

Iron Dysregulation and Inflammagens Related to Oral and Gut Health Are Central to the Development of Parkinson’s Disease
by: Marthinus Janse van Vuuren, et al.
Published: (2020-12-01)

Wild-Type α-Synuclein and Variants Occur in Different Disordered Dimers and Pre-Fibrillar Conformations in Early Stage of Aggregation
by: Adrien Guzzo , et al.
Published: (2022-06-01)

Initiation and propagation of α-synuclein aggregation in the nervous system
by: Baraa A. Hijaz, et al.
Published: (2020-03-01)

Protease-Sensitive and -Resistant Forms of Human and Murine Alpha-Synucleins in Distinct Brain Regions of Transgenic Mice (M83) Expressing the Human Mutated A53T Protein
by: Dominique Bétemps, et al.
Published: (2023-12-01)

Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes
by: Chin-Hsien Lin, et al.
Published: (2018-04-01)

Recent advances in natural products targeting α-synuclein aggregation or clearance in Parkinson's disease
by: Jay Gupta, et al.
Published: (2023-12-01)

Lysophospholipids: A Potential Drug Candidates for Neurodegenerative Disorders
by: Tatsuya Karaki, et al.
Published: (2022-12-01)

Spearmint Extract Containing Rosmarinic Acid Suppresses Amyloid Fibril Formation of Proteins Associated with Dementia
by: Kenjirou Ogawa, et al.
Published: (2020-11-01)

Salivary levels of disease-related biomarkers in the early stages of Parkinson’s and Alzheimer’s disease: A cross-sectional study
by: Masoomeh Sabaei, et al.
Published: (2023-06-01)

The Bacterial Amyloids Phenol Soluble Modulins from <i>Staphylococcus aureus</i> Catalyze Alpha-Synuclein Aggregation
by: Caroline Haikal, et al.
Published: (2021-10-01)

Protein Interactome of Amyloid-β as a Therapeutic Target
by: Vladimir F. Lazarev, et al.
Published: (2023-02-01)

Sesamol as a potential small molecule in inhibiting the induction of neurotoxic amyloids fibrils involved in the pathophysiology of alzheimer's disease
by: Hong-Bin Cai, et al.
Published: (2023-09-01)

Dataset of the molecular dynamics simulations of bilayers consisting of short amyloidogenic peptide VDSWNVLVAG from Bgl2p–glucantransferase of S. cerevisiae cell wall
by: Anna V. Glyakina, et al.
Published: (2016-12-01)

Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease
by: Kyu Hwan Shim, et al.
Published: (2022-12-01)

Systematic Review on Saliva Biomarkers in Patients Diagnosed with Morbus Alzheimer and Morbus Parkinson
by: Michael Wolgin, et al.
Published: (2022-07-01)

α-Synuclein Fibrils as Penrose Machines: A Chameleon in the Gear
by: Francesca De Giorgi, et al.
Published: (2022-03-01)

Production of Recombinant Alpha-Synuclein: Still No Standardized Protocol in Sight
by: Mohammed Al-Azzani, et al.
Published: (2022-02-01)